Prenatal viral infection causes alterations in nNOS expression in developing mouse brains

NeuroReport

Volumn 11, Issue 7, 2000, Pages 1493-1496

  Fatemi, S Hossein ^a   Cuadra, Adolfo E ^a   El Fakahany, Esam E ^a   Sidwell, Robert W ^b   Thuras, Paul ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UTAH STATE UNIVERSITY   (United States)

Author keywords

Human influenza; Neuronal nitric oxide synthase; Neurotoxicity; Prenatal; Schizophrenia

Indexed keywords

NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BRAIN DEVELOPMENT; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GEL ELECTROPHORESIS; IMMUNOREACTIVITY; INFLUENZA; INTRAUTERINE INFECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; SCHIZOPHRENIA; SYNAPTOGENESIS; VIRUS INFECTION;

EID: 0034658201     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200005150-00027     Document Type: Article

References (24)

1. 1. Andreasen NC. Arch Gen Psychiatry 56, 781-793 (1999).
2. 2. Takei N, Mortensen PB, Klaening U et al. Dial Psychiatry 40, 817-824 (1996).
3. 3. Wright P, Takei N and Rifkin L. Am J Psychiatry 152, 1714-1720 (1995).
4. 4. Susser ES, Brown AS and Gorman JM, eds. Prenatal Exposures in Schizophrenia. Washington, DC: American Psychiatric Press, 1999:1-275.
5. 5. Fatemi SH, Sidwell R, Akhter P et al. Synapse 29, 84-88 (1998).
6. 6. Fatemi SH, Emamian ES, Kist D et al. Mol Psychiatry 4, 145-154 (1999).
7. 7. Fatemi SH, Sidwell R, Kist D et al. Brain Res 800, 1-9 (1998).
8. 8. Emamian ES, Fatemi SH and Sidwell RW. Biol Psychiatry 45, 265-266 (1999).
9. 9. Akbarian S, Bunney WE Jr, Potkin SG et al. Arch Gen Psychiatry, 50, 169-177 (1993).
10. 10. Cuadra AE and El-Fakahany E. J Neurochem 71, 571-379 (1998).
11. 11. Bolanos JP, Alameida A, Stewart V et al. J Neurochem 68, 2227-2240 (1997).
12. 12. Moore PK and Handy RLC. Trends Pharm Sci 18, 204-211 (1997).
13. 13. Nicotera P, Brune B and Bagetta G. Trends Pharm Sci 18, 189-190 (1997).
14. 14. Ogilvie P, Schilling K, Billingsley ML and Schmidt HHHW. FASEB J 9, 799-806 (1995)
15. 15. Deng X and Cadet JL. Brain Res 851, 254-257 (1999).
16. 16. Gonzalez-Hernandez T and Rustioni A. J Neurosci Res 55, 198-207 (1999).
17. 17. Harada S, Imaki T, Chikada N et al. Brain Res 821, 322-332 (1999).
18. 18. Ikeda M, Komachi H and Sato L. J Neurosci Res 55, 352-356 (1999).
19. 19. Hornig M, Weissenbock H, Horscroft N and Lipkin WI. Proceedings of the 5th Symposium on the Neurovirology and Neuroimmunology of Schizophrenia and Bipolar Disorder. Bethusda, MD, 1999, p. 48.
20. 20. Wu A and Lin Y. Brain Res 850, 249-252 (1999).
21. 21. Weiss SW, Albers DS and Iadarola MJ. J Neurosci 18, 1725-1734 (1998).
22. 22. Tueting F, Costa E, Dwivedi Y et al. Neuroreport 10, 1329-1334 (1999).
23. 23. Carina-Mallard E, Rehn A and Rees S. Schizophrenia Res 40, 11-21 (1999).
24. 24. Baader SL and Schilling K. J Neurosci 16, 1440-1449 (1996).